• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library

    Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine HCL

    FDA

    Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, 8.4% Sodium Bicarbonate Injection, and Atropine Sulfate Injection Due to the Potential Presence of Glass Particulate Matter

    FDA

    Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Bleomycin for Injection, USP 15 Units Single Dose ONCO-TAIN™ Glass Fliptop Vial Due To The Potential For Presence of Glass Particulate Matter

    FDA

    Enforcement Report - Week of November 15, 2023

    FDA

    Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week of January 11, 2023

    FDA

    Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride

    FDA

    Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable

    FDA

    Hospira Issues a Voluntary Nationwide Recall for One Lot of Propofol Injectable Emulsion

    FDA

    Enforcement Report - Week of September 22, 2021

    FDA

    ICU Medical Issues a Voluntary Nationwide Recall of Aminosyn II 15%

    FDA

    FDA Issues Form 483 to Hospira Inc

    FDA

    Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection

    FDA

    FDA Issues Form 483 to Hospira

    FDA

    FDA Issues Form 483 to Hospira Boulder, Inc.

    FDA

    FDA Issues Form 483 to Hospira Inc.

    FDA

    FDA Issues Form 483 to Hospira Inc. A Pfizer Company

    FDA

    FDA Issues Form 483 to Hospira Inc A Pfizer Company

    FDA

    Hospira, Inc., Issues Recall for one lot of BACTERIOSTATIC WATER for Injection

    FDA

    Hospira, Inc. Issues a Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection

    FDA

    Hospira Healthcare India Receives FDA Warning Letter

    FDA

    Enforcement Report - Week of February 27, 2019

    FDA

    Hospira (Pfizer) Receives FDA Form 483

    FDA

    Enforcement Report - Week of October 31, 2018

    FDA

    Hospira Healthcare India Pvt. Ltd. on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Hospira Healthcare India

    FDA

    Enforcement Report - Week of June 27, 2018

    FDA

    Enforcement Report - Week of June 13, 2018

    FDA

    Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection

    FDA

    Apotex Corp. Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam For Injection

    FDA

    Enforcement Report - Week of March 14, 2018

    FDA

    Hospira Issues a Voluntary Nationwide Recall for Hydromorphone HCL Injection, USP CII

    FDA

    Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP Novaplus®

    FDA

    FDA Issues Form 483 to Hospira Inc. A Pfizer Company (Drug Manufacturer)

    FDA

    Enforcement Report - Week of December 27, 2017

    FDA

    Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection, USP, CII, (2 mg/mL) 1mg/mL Vial, & Levophed®

    FDA

    Hospira Issues A Voluntary Nationwide Recall For One Lot of Vancomycin Hydrochloride for Injection, USP, 750 mg/vial

    FDA

    Enforcement Report - Week of August 16, 2017

    FDA

    Enforcement Report - Week of August 9, 2017

    FDA

    Hospira Healthcare Corporation Issues Recall of Hydromorphone Hydrochloride Injection USP HP 10

    HEALTH CANADA

    ICU Medical Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection

    FDA

    Enforcement Report - Week of July 26, 2017

    FDA

    PharMEDium Services Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate & Succinylcholine Chloride

    FDA

    Advanced Pharma, Inc. D/B/A Avella of Houston Issues Voluntary Nationwide Recalls of Potassium Phosphate & Succinylcholine

    FDA

    Enforcement Report - Week of June 21, 2017

    FDA

    Hospira Issues a Voluntary Nationwide Recall For Sodium Bicarbonate, Succinylcholine Chloride, Potassium Phosphate Injections

    FDA

    Hospira Issues a Voluntary Nationwide Recall For One Lot Of 25% Dextrose Injection, USP (Infant) Due To The Presence of Particulate Matter

    FDA

    Enforcement Report - Week of April 12, 2017

    FDA

    Hospira Inc on Health Canada Inspection List

    HEALTH CANADA

    Anvisa Prohibits Import Products Of Hospira Healthcare India Pvt. Ltd

    ANVISA

    Enforcement Report - Week of March 1, 2017

    FDA

    Hospira Inc Receives FDA Warning letter

    FDA

    Hospira Issues A Voluntary Nationwide Recall Of Vancomycin HCL for Injection

    FDA

    Hospira Healthcare Corporation Issues Voluntary Nationwide Recall Of Marcaine 0.50% Due To Defect Possible That Could Compromise The Sealing Plugs

    HEALTHCANADA

    Hospira Healthcare India Private Limited Fails EDQM Inspection

    EDQM

    Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine

    FDA

    US FDA Enforcement Report- 1/June/2016

    FDA

    US FDA Enforcement Report- 25/May/2016

    FDA

    US FDA Enforcement Report- 11/May/2016

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.